Shantanu Banerji
- Oncology top 10%
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 5
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
-
- Lung Cancer Treatments and Mutations 20
- Lung Cancer Diagnosis and Treatment 8
-
- Metabolomics and Mass Spectrometry Studies 4
- PI3K/AKT/mTOR signaling in cancer 4
-
- Neuroendocrine Tumor Research Advances 4
- Co-authors
- Vallerie GordonDaniel E. MeyersDon MorrisNatasha B. LeighlLeigh C. MurphyBarbara MeloskyParneet CheemaDavid E. Dawe
- Journals
- Journal of Clinical Oncology (4 papers)Genes & Development (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- CanadaUnited StatesIndia
In The Last Decade
Shantanu Banerji
44 papers receiving 855 citations
Peers
Comparison fields: 5 of 104
- Oncology 398
- Cancer Research 175
- Pulmonary and Respiratory Medicine 342
- Genetics 56
- Molecular Biology 323
Countries citing papers authored by Shantanu Banerji
This map shows the geographic impact of Shantanu Banerji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shantanu Banerji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shantanu Banerji more than expected).
Fields of papers citing papers by Shantanu Banerji
This network shows the impact of papers produced by Shantanu Banerji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shantanu Banerji. The network helps show where Shantanu Banerji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shantanu Banerji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 27 | |
| 14 | 2020 | 19 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 18 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 14 | |
| 19 | 2015 | 96 | |
| 20 | 2011 | 126 |
About Shantanu Banerji
Shantanu Banerji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 49 papers that have together received 866 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (11 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Oncology (398 citations), Cancer Research (175 citations) and Pulmonary and Respiratory Medicine (342 citations). Shantanu Banerji has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Vallerie Gordon, Daniel E. Meyers, Don Morris, Natasha B. Leighl, Leigh C. Murphy, Barbara Melosky, Parneet Cheema, David E. Dawe, Gefei Qing and Marshall Pitz. Their work appears in journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.